Clinical trialNCT05803382RecruitingPhase 1Interventional

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

SponsorNational Cancer Institute (NCI)Enrollment30Metastatic Colorectal CarcinomaMetastatic Malignant Solid NeoplasmStage IV Colorectal Cancer AJCC v8Unresectable Colorectal CarcinomaUnresectable Malignant Solid Neoplasm

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Dennis Hsu
University of Pittsburgh Cancer Institute LAO
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
Fa-Chyi Lee
Recruiting
Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
Fa-Chyi Lee
Recruiting
Uf Health Cancer Institute - Gainesville
Gainesville, Florida, United States
Thomas J. George
Recruiting
Memorial Hospital East
Shiloh, Illinois, United States
Active, not recruiting
University of Kansas Clinical Research Center
Fairway, Kansas, United States
Joaquina C. Baranda
Recruiting
University of Kansas Cancer Center
Kansas City, Kansas, United States
Joaquina C. Baranda
Recruiting
University of Kansas Hospital-Westwood Cancer Center
Westwood, Kansas, United States
Joaquina C. Baranda
Recruiting
Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters, Missouri, United States
Active, not recruiting
Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
Active, not recruiting
Siteman Cancer Center at Christian Hospital
St Louis, Missouri, United States
Active, not recruiting
Siteman Cancer Center-South County
St Louis, Missouri, United States
Active, not recruiting
Washington University School of Medicine
St Louis, Missouri, United States
Active, not recruiting
Nyp/columbia University Medical Center/herbert Irving Comprehensive Cancer Center
New York, New York, United States
Active, not recruiting
Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
Chaoyuan Kuang
Recruiting
Montefiore Medical Center-Einstein Campus
The Bronx, New York, United States
Chaoyuan Kuang
Recruiting
Montefiore Medical Center-Weiler Hospital
The Bronx, New York, United States
Chaoyuan Kuang
Recruiting
University of Cincinnati Cancer Center-Uc Medical Center
Cincinnati, Ohio, United States
Davendra P. Sohal
Recruiting
University of Cincinnati Cancer Center-West Chester
West Chester, Ohio, United States
Davendra P. Sohal
Recruiting
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Susanna V. Ulahannan
Recruiting
University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
Anwaar Saeed
Recruiting
Vanderbilt Breast Center at One Hundred Oaks
Nashville, Tennessee, United States
Suspended
Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
Suspended

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 8 Nov 2023
Primary completion: 30 Jun 2027
Completion: 30 Jun 2027
Last update posted: 9 Jul 2026
Registered enrollment: 30
Registry id: NCT05803382

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.